Insights in Vessel Development and Vascular Disorders Using Targeted Inactivation and Transfer of Vascular Endothelial Growth Factor, the Tissue Factor Receptor, and the Plasminogen System
Peter Carmeliet(Khalifa University of Science and Technology), Désiré Collen(Oklahoma Medical Research Foundation), Martin Müller(Leibniz Institute of Polymer Research), Mieke Dewerchin(Vlaams Instituut voor Biotechnologie), Edward F. Plow(Cleveland Clinic Lerner College of Medicine), Georg Breier(University Hospital Carl Gustav Carus), Thomas Luther(Cornell University), Victoria A. Ploplis(University of Notre Dame), Nigel Mackman(University of North Carolina at Chapel Hill), Lieve Moons(Allen Institute for Brain Science), Thomas S. Edgington(Scripps Health), Robert D. Gerard(The University of Texas Southwestern Medical Center), Werner Risau(Max Planck Institute for Heart and Lung Research), András Nagy(University of Pecs)
Cited by 112
Related Papers
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
|Nature|1996|4.2k
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
|Nature|1992|2.3k
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
|Nature Medicine|2001|1.7k
Ligand Binding to Integrins
|Journal of Biological Chemistry|2000|1.3k